These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 26132727)
1. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer. Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
3. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection. Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293 [TBL] [Abstract][Full Text] [Related]
4. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways. Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21. Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147 [TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
7. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro. Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273 [TBL] [Abstract][Full Text] [Related]
8. Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor. Takamura M; Yamagiwa S; Wakai T; Tamura Y; Kamimura H; Kato T; Tsuchiya A; Matsuda Y; Shirai Y; Ichida T; Ajioka Y; Aoyagi Y Int J Oncol; 2010 Jan; 36(1):245-54. PubMed ID: 19956853 [TBL] [Abstract][Full Text] [Related]
9. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813 [TBL] [Abstract][Full Text] [Related]
12. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma. Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022 [TBL] [Abstract][Full Text] [Related]
13. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma. Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145 [TBL] [Abstract][Full Text] [Related]
14. Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance. Cao J; Zhang C; Jiang GQ; Jin SJ; Gao ZH; Wang Q; Yu DC; Ke AW; Fan YQ; Li DW; Wang AQ; Bai DS Mol Med Rep; 2019 Aug; 20(2):1915-1924. PubMed ID: 31257527 [TBL] [Abstract][Full Text] [Related]
15. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
16. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
17. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939 [TBL] [Abstract][Full Text] [Related]
18. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype. Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381 [TBL] [Abstract][Full Text] [Related]
19. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells. Qiu C; Bu X; Jiang Z Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920 [TBL] [Abstract][Full Text] [Related]
20. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]